Medifast Inc (MED) insider trading
Recent insider transactions reported to the SEC on Form 4 — directors and officers buying or selling their own company’s stock. Sourced directly from public SEC filings, latest filed Nov 20, 2026.
- Filings shown
- 14
- Open-market buys
- 17
- Open-market sells
- 2
- Buys, 10b5-1 box not checked
- 17 of 17
Counts cover the 14 most recent Form 4 filings Tradune holds for MED (filed May 12 – Nov 20, 2026); the score below covers only the trailing 90 days (11 buys, 2 sells). SEC EDGAR Form 4 filings for MED last checked Nov 21, 2026, 09:00 UTC; the latest MED filing Tradune holds was filed Nov 20, 2026. This is not guaranteed to be the complete record — see MED's full Form 4 filing history on SEC EDGAR.
Open-market activity, last 90 days
Purchases (Form 4 code P) and sales (code S) on the 6 filings Tradune holds for MED filed Aug 26 – Nov 20, 2026. Grants, exercises, tax withholding and the other Form 4 transaction codes are left out.
2 open-market sales by Rule 10b5-1 checkbox
- On filings with the 10b5-1 box checked
- 2 sales· 19,089 sh
- checkbox disclosed
- On filings with the box not checked
- 0 sales· 0 sh
- not proof that no plan exists
- Not comparable
- 0 sales· 0 sh
- filed before Apr 1, 2023, or no checkbox value in the filing data
Counts are Form 4 lines as filed. The checkbox is one per filing, so every sale on a filing with the box checked is counted there even if only some of its transactions were under a plan; it records what the filer disclosed, and the three categories are not a judgement about why a sale was made.
| Insider | Buys | Sells | Shares bought | Shares sold | Value |
|---|---|---|---|---|---|
| Parsa KiaiDirector | 11 | 0 | 147,733 | — | +$1,791,557 |
| Daniel R. ChardDirector | 0 | 2 | — | 19,089 | −$226,289 |
Value = shares × the price reported on each Form 4 (+ purchases, − sales); every open-market line in this window disclosed a price.
Insider-activity score
56/ 100
Summarises ~90 days of public SEC Form 4 activity — more distinct buyers, officer involvement and net buying score higher. A description of filing activity, not a rating or buy signal. How this score is computed →
Get alerted when insiders buy the stocks you own
Add your holdings — no brokerage login — and Insider Radar sends a Telegram alert when an open-market Form 4 buy of $100,000 or more is filed on a stock you hold or watch.
Free for everyone right now · no card · nothing to buy
How to read this: an open-market purchase (Form 4 code P) is a buy at the market price with the insider’s own money, as opposed to a grant, award or option exercise; an open-market sale is code S. When two or more distinct insiders report open-market purchases in the same 90-day window, this site labels that a cluster — a definition, not a forecast; see insider cluster buying. “Held after” is Form 4 Table I column 5; “Change” = shares ÷ holdings before the trade (held after − shares for an acquisition, held after + shares for a disposition).
Insider Buying at MED
Insiders reported 17 open-market purchases of MED between May 12, 2026 and Nov 20, 2026, across 2 distinct buyers. The most recent purchase was reported by Parsa Kiai (Director) on Nov 19, 2026. Grants, option exercises, and tax-withholding transactions are excluded from these counts.
Recent Form 4 filings
Source: SEC EDGAR Form 4 · transaction codes explained
| Transaction | Shares | Price | Held after | Change† | Date |
|---|---|---|---|---|---|
| Open-market purchase 10b5-1 box not checked | 2,450 | $12.05 | 23,795 (indirect) | +11% | Nov 19, 2026 |
| Open-market purchase 10b5-1 box not checked | 82,700 | $12.05 | 804,221 (indirect) | +11% | Nov 19, 2026 |
| Open-market purchase 10b5-1 box not checked | 8,630 | $12.16 | 721,521 (indirect) | +1.2% | Nov 18, 2026 |
| Open-market purchase 10b5-1 box not checked | 256 | $12.16 | 21,345 (indirect) | +1.2% | Nov 18, 2026 |
† change in this filer’s own reported holding line (Form 4 Table I, col. 5), not of total company ownership; small prior holdings produce large percentages, so under 100 shares the prior holding is shown instead.
“10b5-1 box checked” = the filer checked the Form 4 box stating that a transaction on the filing was made under a plan intended to satisfy Rule 10b5-1(c); “10b5-1 box not checked” = the box was left blank, which does not prove that no plan exists. The box applies to Form 4s filed from April 1, 2023; older filings, and boxes we could not read, carry no tag. What the 10b5-1 box means.
| Transaction | Shares | Price | Held after | Change† | Date |
|---|---|---|---|---|---|
| Open-market purchase 10b5-1 box not checked | 661 | $13.03 | 21,089 (indirect) | +3.2% | Nov 4, 2026 |
| Transaction | Shares | Price | Held after | Change† | Date |
|---|---|---|---|---|---|
| Open-market purchase 10b5-1 box not checked | 158 | $12.24 | 20,428 (indirect) | +0.8% | Oct 28, 2026 |
| Open-market purchase 10b5-1 box not checked | 5,399 | $12.24 | 712,891 (indirect) | +0.8% | Oct 28, 2026 |
| Transaction | Shares | Price | Held after | Change† | Date |
|---|---|---|---|---|---|
| Open-market sale 10b5-1 box checked | 9,544 | $11.73 | 130,609 (indirect) | −6.8% | Sep 29, 2026 |
| Open-market sale 10b5-1 box checked | 9,545 | $11.98 | 140,153 (indirect) | −6.4% | Sep 28, 2026 |
| Transaction | Shares | Price | Held after | Change† | Date |
|---|---|---|---|---|---|
| Open-market purchase 10b5-1 box not checked | 41,975 | $12.26 | 707,492 (indirect) | +6.3% | Aug 26, 2026 |
| Open-market purchase 10b5-1 box not checked | 1,175 | $12.26 | 20,270 (indirect) | +6.2% | Aug 26, 2026 |
| Transaction | Shares | Price | Held after | Change† | Date |
|---|---|---|---|---|---|
| Open-market purchase 10b5-1 box not checked | 4,211 | $12.00 | 665,517 (indirect) | +0.6% | Aug 24, 2026 |
| Open-market purchase 10b5-1 box not checked | 118 | $12.00 | 19,095 (indirect) | +0.6% | Aug 24, 2026 |
| Transaction | Shares | Price | Held after | Change† | Date |
|---|---|---|---|---|---|
| Open-market purchase 10b5-1 box not checked | 41,975 | $11.60 | 661,306 (indirect) | +6.8% | Aug 20, 2026 |
| Open-market purchase 10b5-1 box not checked | 1,175 | $11.60 | 18,977 (indirect) | +6.6% | Aug 20, 2026 |
| Open-market purchase 10b5-1 box not checked | 799 | $11.66 | 17,802 (indirect) | +4.7% | Aug 19, 2026 |
| Open-market purchase 10b5-1 box not checked | 28,538 | $11.66 | 619,331 (indirect) | +4.8% | Aug 19, 2026 |
| Transaction | Shares | Price | Held after | Change† | Date |
|---|---|---|---|---|---|
| Grant / award | 11,680 | — | 11,680 | — | May 26, 2026 |
| Grant / award | 6,739 | — | 18,419 | +58% | May 26, 2026 |
| Transaction | Shares | Price | Held after | Change† | Date |
|---|---|---|---|---|---|
| Grant / award | 11,680 | — | 11,680 | — | May 26, 2026 |
| Grant / award | 7,637 | — | 19,317 | +65% | May 26, 2026 |
| Transaction | Shares | Price | Held after | Change† | Date |
|---|---|---|---|---|---|
| Grant / award | 11,680 | — | 35,697 | +49% | May 26, 2026 |
| Transaction | Shares | Price | Held after | Change† | Date |
|---|---|---|---|---|---|
| Grant / award | 11,680 | — | 42,229 | +38% | May 26, 2026 |
| Transaction | Shares | Price | Held after | Change† | Date |
|---|---|---|---|---|---|
| Grant / award | 11,680 | — | 31,225 | +60% | May 26, 2026 |
| Transaction | Shares | Price | Held after | Change† | Date |
|---|---|---|---|---|---|
| Grant / award Restricted Stock Units (cash settled) | 11,680 | — | — | — | May 26, 2026 |
| Transaction | Shares | Price | Held after | Change† | Date |
|---|---|---|---|---|---|
| Open-market purchase 10b5-1 box not checked | 2,500 | $12.53 | 30,549 | +8.9% | May 11, 2026 |
| Open-market purchase 10b5-1 box not checked | 2,500 | $12.65 | 28,049 | +9.8% | May 8, 2026 |
Insider filings reported around the same time
Other companies whose most recent Form 4 was filed closest to MED's (Nov 20, 2026).
Frequently asked about MED insider activity
How many insiders bought MED stock in these Form 4 filings?
2 distinct insiders at Medifast Inc reported 17 open-market purchases (Form 4 code P) of MED shares between May 12, 2026 and Nov 20, 2026, the most recent filed by Parsa Kiai (Director) on Nov 19, 2026. Grants, option exercises, and tax-withholding transactions are excluded from these counts.
Who filed the most recent Form 4 for MED?
The most recent Form 4 on this page was filed by Parsa Kiai (Director) on Nov 20, 2026, reporting 4 transactions. The original document is linked from the filing list above on SEC EDGAR. Amended filings (Form 4/A) may later revise reported figures.
What was the largest open-market MED insider purchase shown?
The largest open-market purchase among the filings shown was 82,700 MED shares at $12.05 (about $996,237) by Parsa Kiai (Director) on Nov 19, 2026. Value is shares × the price reported on the Form 4; its Rule 10b5-1 box is not checked.
Do the recent MED insider purchases have the Form 4 10b5-1 box checked?
No. All 17 MED open-market purchases shown were reported with the Rule 10b5-1 box not checked. A blank box records what the filer disclosed; it does not prove that no plan exists. Latest: Parsa Kiai (Director) on Nov 19, 2026, 82,700 shares.
New to Form 4s? The transaction codes, the 90-day window and the 0–100 score are defined on the insider-activity score methodology page.
Get insider alerts for MED — and your whole portfolio
Tradune watches SEC Form 4 filings and flags insider-cluster buying across everything you hold, routed to you automatically. Free for everyone right now · no card · nothing to buy
This score summarizes SEC Form 4 filing activity over the trailing 90 days. It is descriptive, not predictive — not a rating, recommendation, or investment advice. Data: SEC EDGAR (public domain), as filed; amendments may revise figures. Tradune is not a registered investment adviser.
Data as filed; amended filings (Form 4/A) may revise figures. Sales may occur under prearranged Rule 10b5-1 trading plans.